In Brief: Boehringer Mannheim Corp.
This article was originally published in The Gray Sheet
Boehringer Mannheim Corp.: Submits 510(k) to FDA for an expansion of labeling for its CoaguChek prothrombin time (PT) test system to include patient self-testing. The system has been marketed for professional use since August 1993 and has been in trials for more than a year for the home-use indication ("The Gray Sheet" May 6, 1996, I&W-4)...
You may also be interested in...
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Netherlands' Authority for Consumers and Markets has reprimanded a dietary supplements player for purchasing fake followers and likes on social media to exaggerate the popularity of its products. It is the first case of its kind in the country.